Abstract
We adopted a commonly used epidemiologic model known as Susceptible-Infectious-Recovered (SIR) by adding a compartment vaccination to locate the COVID-19 hotspot in Bangladesh. Using data from the Directorate General of Health Services (DGHS), we utilized the Susceptible-Vaccinated-Infectious-Recovered (SVIR) model to assess vaccine efficacy. Vaccination against COVID-19 has begun in industrialized nations and will be completed by early December 2020. Before 2023, mass vaccination for impoverished or low-income nations would be extremely difficult. Bangladesh, a lower-middle-income country, started a statewide COVID- 19 immunization effort in early February 2021. This study aimed to recognize the effectiveness of vaccination on the infected population in Bangladesh. Additionally, the study aimed to create public awareness of the importance of vaccination during a pandemic.
 GANIT J. Bangladesh Math. Soc. 43.1 (2023) 045- 062
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
